Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-12

Clinical Trial Update: The Effects of Rifaximin Therapy in Irritable Bowel Syndrome [NA]

View source ↗

Summary

A completed clinical trial evaluating rifaximin for irritable bowel syndrome (IBS) conducted by Bezmialem Vakif University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rifaximin (rifaximin)

Snippet

Sponsor: Bezmialem Vakif University | Conditions: IBS | NA | Status: COMPLETED